1 terminated. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Terminated 1 |
Follow pafuramidine: new trials by email Literature Review of pafuramidine trials Research Report on pafuramidine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| DB289 Versus TMP-SMX for the Treatment of Acute Pneumocystis Jiroveci Pneumonia (PCP) Pafuramidine maleate (DB289), Trimethoprim-Sulfamethoxazole (TMP-SMX) - Pneumonia, Interstitial Plasma Cell, Pneumocystis Carinii Pneumonia | Phase 3 | Terminated | Immtech Pharmaceuticals, Inc | 48 | 2006-05-01 | 2013-03-07 |
Acquired Immunodeficiency Syndrome (1) · Dyspnea (1) · HIV Infections (1) · Hypoxia (1) · Lung Diseases (1) · Pneumonia, Pneumocystis (1)
Immtech Pharmaceuticals, Inc (1)
United States (1)
Amanda Peppercorn, MD (1) · Carl Fichtenbaum, MD (1) · Jose Vazquez, MD (1) · Judith Aberg, MD (1) · Kathleen Mullane, DO (1) · Laurence Huang, MD (1) · Preston Church, MD (1)